Background: At the onset of embryogenesis, key developmental regulators called determinants are activated asymmetrically to specify the body axes and tissue layers. In C. elegans, this process is regulated in part by a conserved family of CCCH-type zinc finger proteins that specify the fates of early embryonic cells. The asymmetric localization of these and other determinants is regulated in early embryos through motor-dependent physical translocation as well as selective proteolysis. Results: We show here that the CCCH-type zinc finger protein OMA-1 serves as a nexus for signals that regulate the transition from oogenesis to embryogenesis. While OMA-1 promotes oocyte maturation during meiosis, destruction of OMA-1 is needed during the first cell division for the initiation of ZIF-1-dependent proteolysis of cell-fate determinants. Mutations in four conserved protein kinase genes-mbk-2/Dyrk, kin-19/CK1a, gsk-3, and cdk-1/CDC2-cause stabilization of OMA-1 protein, and their phenotypes are partially suppressed by an oma-1 loss-of-function mutation. OMA-1 proteolysis also depends on Cyclin B3 and on a ZIF-1-independent CUL-2-based E3 ubiquitin ligase complex, as well as the CUL-2-interacting protein ZYG-11 and the Skp1-related proteins SKR-1 and SKR-2. Conclusions: Our findings suggest that a CDK1/Cyclin B3-dependent activity links OMA-1 proteolysis to completion of the first cell cycle and support a model in which OMA-1 functions to prevent the premature activation of cell-fate determinants until after they are asymmetrically partitioned during the first mitosis.
Introduction
In many organisms, fertilization triggers a remarkable cascade of events, including cytoskeletal reorganization and the subsequent asymmetric localization of factors that regulate gene expression and cell fate [1] . In C. elegans, the initial anterior-posterior polarity of the embryo is established after fertilization and completion of female meiosis. Possible links between oocyte meiotic maturation and initial establishment of cell polarity have been reported previously. For example, prior to fertilization, sperm-derived signals trigger the completion of the meiosis I to II transition and promote ovulation [2] [3] [4] , and after fertilization, interactions between the sperm-derived astral microtubules and the cortex of the embryo define the posterior pole. This initial polarity cue, in turn, triggers the actin/myosin-based partitioning of both cytoplasmic and cortical factors [5] .
Among the developmentally important factors localized during this process are the transcriptional regulator SKN-1 and several members of the Cys3-His zinc finger protein family, including PIE-1 and MEX-5 [6] [7] [8] .
The PIE-1 family member OMA-1 (also called MOE-1) and its close homolog OMA-2 are required for oocyte maturation [9, 10] . In the distal gonad, OMA protein levels are low due to GLD-1-dependent translational inhibition [11] . OMA protein levels begin to increase at the pachytene stage of meiosis I, reach a maximum level in the maturing oocyte, and quickly fall to much lower levels during the first mitosis [9, 10] . A gain-of-function oma-1 mutation that stabilizes the OMA-1 protein results in mislocalization of PIE-1 and MEX-5 and induces an excess-endoderm phenotype that correlates with ectopic expression of the proendoderm transcription factor, SKN-1 [12] . OMA-1 destruction depends on the Dyrkkinase homolog MBK-2, which also downregulates the Katanin homolog MEI-1 at the end of meiosis [13] [14] [15] . However, unlike MEI-1 protein, OMA-1 begins to disappear only after the fertilized egg enters the first mitosis. How the destruction of OMA-1 is timed to coincide with the first mitosis is not yet known.
The PIE-1 and MEX-5 proteins are present at high levels throughout the oocyte and fertilized egg, but they become localized asymmetrically to opposite ends of the embryo prior to the first mitosis. The MEX-5 protein is localized to the anterior half of the fertilized egg via a mechanism that depends on the PAR proteins [7] . MEX-5, in turn, promotes the posterior localization of PIE-1, and does so in part through the activation of the ZIF-1-dependent CUL-2-mediated proteolysis of PIE-1 in the anterior region of the embryo [16] .
Here we describe several new mutants with phenotypes very similar to that of the previously described oma-1 gain-of-function mutant. These mutations include two new alleles of oma-1, as well as two special alleles of the major cell-cycle kinase cdk-1, one allele of the 13 kDa CDK-1 binding partner, cks-1, and one allele of the Dyrk-kinase homolog, mbk-2. We show that all of these mutants exhibit stabilization of OMA-1 and that all are suppressed in part by downregulating OMA-1 expression. OMA-1 destruction also requires Cyclin B3, the GSK-3 and KIN-19/CK1a kinases, a ZIF-1-independent CUL-2-based E3 ubiquitin ligase complex, the CUL-2-interacting protein ZYG-11, and the Skp1-related proteins SKR-1 and SKR-2. Our findings support a model in which OMA-1 functions to prevent the premature activation of cell-fate determinants and provide insights into regulatory mechanisms that link the asymmetric activation of determinants to the completion of the first cell cycle.
Results and Discussion

Isolation of Extra-Gut Mutants
In very large-scale screens for conditional and maternaleffect embryonic-lethal mutants, we identified several mutants with excess endoderm and a suite of other defects in cell polarity and cell-fate specification that were very similar to the phenotype caused by depletion of the conserved protein kinase GSK-3 [17] (see Figure S1 in the Supplemental Data available with this article online). We later found that these mutants were also similar phenotypically to a gain-of-function (gf) allele of the oocyte maturation factor oma-1 [12] . For example, we found that all of these mutants exhibit mislocalization of cellfate determinants such as PIE-1 and SKN-1 ( Figure S2 and data not shown).
Our genetic and molecular studies revealed that these new mutants include one allele of the Dyrk family kinase homolog mbk-2(ne3442), two new gain-of-function alleles of oma-1(ne411gf and ne3800gf), two alleles of the cyclin-dependent protein kinase cdk-1(ne236 and ne2257), and one allele of a highly conserved 13 kDa CDK-1-interacting protein, cks-1(ne549) (Figure 1 ).
Degradation of OMA-1 Depends on the MBK-2, CDK-1, and GSK-3 Kinases All three gain-of-function oma-1 mutants cause stabilization of the OMA-1 protein ( [12] data not shown), and one of the genes identified in our screen, mbk-2, was recently linked to regulation of OMA-1 destruction [13] . We therefore asked whether the other newly identified mutant strains might also exhibit OMA-1 stabilization. In wild-type animals, OMA-1 and its homolog OMA-2 accumulate during oogenesis and remain high until the 1-cell stage, but rapidly decline during the first and second mitosis [9, 10] (Figure 2 and Figure S3 ). We examined the timing of OMA-1 degradation by monitoring the expression of an OMA-1::GFP protein. We found that OMA-1 protein levels remain high in gsk-3, cdk-1, cks-1, and mbk-2 mutant embryos ( Figure 2 , Figure S3 , and data not shown). Furthermore, consistent with the idea that the cell-fate defects in these mutants result from OMA-1 (and to some extent OMA-2) stabilization, we found that each mutant was suppressed by loss-of-function oma-1 (or oma-2) mutations (Table 1 , and data not shown). In the case of the cdk-1(ne2257) and gsk-3(nr2047) mutants, substantial suppression was observed in oma-1 (te33) mutants ( Table 1 ). The mbk-2(ne3442) mutant was only weakly suppressed by oma-1(te33) ( Table 1) .
These results suggest that the mbk-2(ne3442) mutation also affects additional developmental functions of MBK-2 [13] . Likewise, the incomplete suppression observed in cdk-1 and gsk-3 backgrounds by oma-1(te33) loss of function could reflect the existence of defects in developmental mechanisms unrelated to Partial amino acid sequence alignments for the MBK-2 protein and other Dyrk-family kinases including human Dyrk2 and 3, fission yeast Pom1, and budding yeast Yak1 (A), for the OMA-1 protein and its C. elegans and C. briggsae homologs (OMA-2 and CBP05155, respectively) (B), for the CDK-1 protein and its human, fruit fly, and budding yeast homologs (C), and for the CKS-1 protein and its human, fruit fly, and budding yeast homologs (D). The amino acid substitutions found in temperature-sensitive or maternal-effect lethal alleles of each protein are indicated in red above the corresponding residue in each alignment. In (A), an arginine residue that is required in proline-directed kinases for P+1 specificity is boxed in red. Potential MBK-2 phosphorylation sites in OMA-1 and its homologs are underlined in (B). In (C), a threonine residue that is phosphorylated by CAK kinase is boxed in red. The T loop/activation domain is underlined.
OMA-protein stabilization. However, given that partial suppression was also observed in oma-2 loss-of-function mutants, it is likely that the failure to achieve full suppression reflects, at least in part, the persistence of the OMA-2 protein in these double mutant backgrounds. Unfortunately, it is not possible to construct triple mutant embryos lacking both OMA proteins due to the requirement for at least one intact oma gene for oocyte maturation.
GSK3 and KIN-19 Influence Wnt Signaling Indirectly through OMA-1 Endoderm specification is regulated by both the Wnt [18, 19] and Src [20] pathways in C. elegans. A previous 
a C-derived gut specification was followed in laser-operated embryos.
b Phenotype of oma-1 (zu405) was previously scored by Lin [12] . study has shown that the Wnt-responsive Tcf/Lef-related protein POP-1 is misregulated in oma-1(zu405gf) mutants [12] , and we found that SRC-1-dependent phosphotyrosine staining at the junction between signaling cells is reduced in oma-1(ne411gf) mutants (data not shown). These findings suggest that stabilized OMA-1 interferes with both the Wnt-and Src-signaling pathways, perhaps by perturbing the localization of SKN-1, PIE-1, and other upstream maternal determinants that specify the fates of the signaling and responding cells. Previous genetic studies have suggested that GSK-3 and a Casein kinase 1a (CK1a) homolog, KIN-19, have direct functions in the Wnt/wingless pathway for endoderm specification and spindle orientation [17, 21, 22] . We found that RNAi targeting kin-19 also causes OMA-1 stabilization ( Figure 2 and Figure S3 ). The finding that both kinases are required for OMA-1 proteolysis and that the cell fate and spindle-orientation defects of gsk-3 mutants are suppressed by lowering OMA-1 levels suggests that these kinases may indirectly regulate P2/ EMS signaling by lowering OMA protein levels in early embryos.
OMA-1 Ubiquitination Machinery
In a previous genetic screen, we identified one additional mutant allele, zu136, which exhibits an extraendoderm phenotype similar to that of oma-1(gf). Genetic mapping and complementation analysis revealed that zu136 is allelic to zyg-11. Although the molecular function of ZYG-11 is not yet determined, it has been reported that ZYG-11 acts with a CUL-2-based E3 ubiquitinligase to control progress through meiosis II [23, 24] . Degradation of OMA-1 was previously reported to depend on CUL-2 [16] . We therefore examined the role of ZYG-11 and found that OMA-1 degradation is disrupted in zyg-11(RNAi) embryos (Figure 2 and Figure S3 ). Similar results were obtained in zyg-11(zu136) mutants (data not shown). Thus, the destruction of OMA-1, like the destruction of PIE-1 and other maternal determinants, depends on a CUL-2/E3 complex [16] . However, OMA-1 differs from PIE-1 in that its destruction is not dependent on the SOCS protein ZIF-1 [16] . This difference in the adaptor proteins required for destruction of OMA-1 versus other zinc finger family members may help explain how OMA-1 destruction precedes and appears to regulate the destruction of PIE-1 (see below).
CUL-2 is a core component of the ECS (Elongin C-Cul2-SOCS box) E3 ubiquitin ligase complex. However, we found that RNAi targeting elc-1 (elongin C), elb-1 (elongin B), or both caused, at most, a modest increase in OMA-1 levels (data not shown). Instead, we found that destruction of OMA-1 is largely dependent on the Skp1 homologs SKR-1 and SKR-2 (data not shown). Since it has been reported that both SKR-1 and SKR-2 interact with CUL-1 as an SCF (Skp1-Cul1-F-box) complex, but not with CUL-2 [25, 26] , it is unclear at present whether SKR-1 and SKR-2 work directly with CUL-2 in OMA-1 destruction.
The zyg-11, skr-1/skr-2, and cul-2 mutant embryos have pleiotropic effects on polarity and may thus indirectly affect OMA-1 degradation. In order to test the possibility that the timing of OMA-1 proteolysis is influenced by cell-polarity factors, we examined OMA-1 localization in par-1(RNAi) embryos [27] . We found that OMA-1 degradation is still coupled to the cell cycle and occurs as in wild-type embryos, at the onset of the first mitosis ( Figure 2 ). This result suggests that initiation of OMA-1 degradation is not regulated by par-1-dependent anterior-posterior cell polarity. However, whereas OMA-1 disappears more slowly from the posterior blastomere P1 in wild-type embryos, we observed that OMA-1 instead disappears almost simultaneously from both 2-cell stage blastomeres in par-1 mutants (Figure 2 ). mbk-2(ne3442), cdk-1(ne236 and ne2257), and cks-1(ne549) Are Nonnull Alleles The newly identified alleles of cdk-1, cks-1, and mbk-2 are nonnull alleles. Null alleles of each of these mutants exhibit additional phenotypes, including sterility and cell-division defects (in the case of cdk-1 and cks-1 mutants) and polarity and spindle-positioning defects (in the case of mbk-2 null mutants) [13] [14] [15] . The mbk-2 (ne3442) allele is a temperature-sensitive mutation that alters a conserved amino acid located just two amino acids away from an arginine residue required for substrate recognition in proline-directed kinases [28] (Figure 1A) . The proximity of the ne3442 lesion to this conserved residue could alter substrate recognition by the mutant protein and may thus explain why this allele is strongly defective in OMA-1 destruction but exhibits no apparent defects in other MBK-2 functions required for microtubule stability and spindle positioning [13] [14] [15] (data not shown).
CDK-1 and its 13 kDa binding partner CKS-1 are essential cell-cycle regulators that are highly conserved from yeast to humans. Depletion of maternal cdk-1 or cks-1 by RNAi causes a 1-cell meiotic arrest [29, 30] . In contrast, cdk-1(ne236), cdk-1(ne2257), and cks-1(ne549) homozygotes have no obvious larval phenotypes and produce mutant embryos with normal cell divisions and well-differentiated cells and tissues ( Figure S1 , data not shown). Both CDK-1 mutations alter residues within the T loop (or activation loop) of CDK-1 ( Figure 1C ), a region implicated in cyclin binding [31] . The CKS-1 lesion is predicted to disrupt a single intramolecular hydrogen bond based on the crystal structure of CKS-1 [32] (Figure 1D ). CDK1/CDC2 kinases are regulated in part through their interactions with cyclins. We therefore used RNAi to search for cyclins required for OMA-1 destruction. The C. elegans genome contains a single cyclin A gene (cya-1), three cyclin B genes (cyb-1, cyb-2.1, and cyb-2.2), and a single cyclin B3 gene (cyb-3) [33] . Despite the cell-cycle delay associated with cyclin RNAi [34] , we found that OMA-1 protein is degraded with normal timing, as cells first enter mitosis, in cyclin A-or cyclin B-depleted embryos (Figure 3 ). In contrast, we found that OMA-1 protein is dramatically stabilized in embryos depleted for cyclin B3 (Figure 3) .
We next examined the effects of the mutations in CDK-1 and CKS-1 proteins on their activities and interactions with each other and with Cyclin B and Cyclin B3. We found that the CDK-1 protein encoded by the ne2257 mutant allele, CDK-1(I173F), binds to CKS-1, CYB-1, and CYB-3 as efficiently as does wild-type CDK-1 ( Figures  4A, 4B , and 4E) and that both cyclin complexes recovered from cdk-1(ne2257) mutant extracts exhibit near wild-type activity toward histone H1 (Figures 4A and  4B ). In contrast, we found that the CKS-1 protein encoded by ne549, CKS-1(Y10F), exhibits reduced binding to wild-type CDK-1 ( Figure 4F ) and, although the binding of CDK-1 to the cyclins was not altered detectably, we found that CDK-1/CYB-3 activity toward histone H1 is reduced to 60% of wild-type in cks-1(ne549) mutants ( Figure 4C ). Taken together, these findings suggest that, consistent with the lack of visible defects in the cell cycle, these alleles exhibit, at most, weak effects on the histone-H1 kinase activity of the CYB-1 and CYB-3 complexes.
MBK-2 Phosphorylates OMA-1
Since OMA-1 degradation is impaired in mbk-2, gsk-3, kin-19, and cdk-1 mutants, we hypothesized that some or all of these protein kinases may directly phosphorylate OMA-1. Scanning of the OMA-1 sequence revealed two potential MBK-2 phosphorylation sites (T239 and S302) [28] that are conserved among C. elegans and C. briggsae OMA proteins ( Figures 1B and 5A) . Interestingly, T239 is located next to proline 240, which is mutated in both the original and our newly identified OMA-1 gain-of-function alleles [12] (Figure 1B) . We found that MBK-2 efficiently phosphorylates both potential MBK-2 sites in these OMA-1 fragments ( Figure 5B ). Furthermore, when both potential MBK-2 sites were mutated (S238A; T239A or S302A), the phosphorylation of the corresponding fragments was abolished. Importantly, the proline to leucine change (P240L) found in the oma-1 gain-of-function mutants (zu405 and ne411) also prevented phosphorylation at T239 ( Figure 5B ). Taken together, these results suggest that MBK-2 can phosphorylate OMA-1 on T239 and S302 in vitro and that phosphorylation of T239 (at least) is important for the destruction of OMA-1 protein in vivo.
We did not detect any CDK-1-dependent phosphorylation of OMA-1 (data not shown), suggesting that CDK-1 may not directly regulate OMA-1. In contrast, we found that both human CK1 (a very close homolog of and C. elegans GSK-3 exhibit weak activity toward fulllength OMA-1 protein and that this activity is enhanced after pretreatment of OMA-1 with MBK-2 ( Figure S4 ). These findings suggest that KIN-19 and GSK-3 may directly phosphorylate OMA-1 in an MBK-2-dependent manner.
OMA-1 Inhibits ZIF-1-Dependent Proteolysis of PIE-1
Stabilization of OMA-1 in early embryos is correlated with the persistent expression of several other key developmental regulators [12] (Figure S2 ). This raises the possibility that the OMA proteins may normally function in early embryos to prevent the premature destruction of these developmental regulators. The soma-specific degradation of PIE-1 and of other CCCH-type zinc finger proteins such as MEX-1 and POS-1 depends on a CUL-2/E3 complex and its substrate-specific component ZIF-1 [16] . In order to ask if stabilized OMA-1 interferes with ZIF-1-dependent proteolysis, we employed an assay system described by DeRenzo et al. [16] that utilizes a par-1 mutant background and a GFP construct fused to the first zinc-finger domain (ZF1) of PIE-1 (GFP::ZF1) to follow ZIF-1-dependent destruction. In par-1 mutants, GFP::ZF1 protein is expressed uniformly in all blastomeres until the 2-cell stage but is degraded rapidly when the embryo divides from two to four cells. This degradation is dependent on ZIF-1. We found that in gsk-3(RNAi), cdk-1(ne2257), and oma-1(ne411gf) mutants, the GFP::ZF1 signal remains high from the 4-to 8-cell stage ( Figure 6A ), suggesting that stabilized OMA-1 interferes with ZIF-1-dependent proteolysis. It was previously shown that MEX-5 activates ZIF-1-dependent proteolysis [16] . Since both MEX-5 and OMA-1 are CCCH-type zinc finger proteins similar to the RNA binding protein TIS11 [35] , it is possible that they exert their effects by regulating the translation of the zif-1 mRNA.
OMA-1 Destruction and Its Implications
Our findings support a model in which OMA-1 functions to prevent the premature destruction of maternal factors until after the first asymmetric division of the embryo ( Figure 6B ). In oocytes and newly fertilized embryos, PIE-1 and MEX-5 coexist within the cytoplasm. However, after fertilization, these proteins rapidly become localized to opposite regions of the 1-cell embryo in a manner that depends on the PAR proteins and the actin cytoskeleton [36] . During this process, the majority of the PIE-1 protein becomes localized to the posterior of the 1-cell embryo. Following the first mitosis, MEX-5-dependent activity, now enriched in the anterior blastomere, promotes the ZIF-1-dependent proteolysis of any residual PIE-1 protein present in the anterior of the embryo. Conceivably, OMA-1 inhibits ZIF-1-dependent proteolysis to permit PIE-1 and MEX-5 to coexist in the embryo prior to the first asymmetric division. Destruction of OMA-1 at the end of the first mitosis might then be an important trigger that helps to drive the asymmetric expression of PIE-1. According to this model, when MBK-2 phosphorylates and promotes destruction of the microtubulesevering Katanin homolog MEI-1 during meiosis (Stitzel et al., this issue of Current Biology [37] ), MBK-2 may simultaneously phosphorylate OMA-1 (this work, [37, 38] ). However, unlike MEI-1, OMA-1 is not degraded until after the first mitosis. Instead, further regulatory events involving KIN-19, GSK-3, and CDK-1 are required for OMA-1 destruction. These events may include direct phosphorylations that depend on a conformational change in OMA-1 or changes in the localization of the regulators. Consistent with this idea, it has been recently shown that OMA-1 is directly phosphorylated by GSK-3 and that this phosphorylation is important for OMA-1 destruction [38] . Regulation by CDK-1 provides an important link between OMA-1 proteolysis and completion of the first cell cycle and may thus guarantee that ZIF-1/CUL-2/E3-dependent proteolysis commences only after MEX-5 and PIE-1 are physically partitioned by cytokinesis.
There are precedents for CDK1/CDC2 as a regulator of cell polarity. For example, a mutation that reduces Drosophila CDK1 activity results in a loss of polarity in neuroblasts, supporting a model in which different thresholds of CDK1 kinase activity are required for the cell-cycle and polarity functions of CDK1 [39] . In contrast, our cdk-1(ne2257) mutants exhibit wild-type kinase activity toward histone H1 and may thus perturb the recognition of only a subset of CDK-1 substrates, or may perturb kinase-independent activities of the CKS-1 and CDK-1 proteins [40] . How cell-fate specification and polarity-signaling mechanisms are linked to the cell cycle remains almost entirely unknown at present. The special alleles of cdk-1 and cks-1 described here provide rare and important clues to these fundamental mechanisms.
Experimental Procedures Genetics
All strains were handled and cultured as described by Bei et al. [20] . The temperature-sensitive embryonic lethal screening was performed as described in Pang et al. [15] .
RNA Interference
RNA interference (RNAi) was performed as described in Bei et al. [20] by feeding or injecting double-stranded (ds) RNA at concentration of 1 mg/ml for single dsRNA and 1 mg/ml each for double dsRNAs injection. Embryos collected 24 hr after injection were scored for phenotypes at the appropriate temperature.
Plasmid Construction
A full-length MBK-2 cDNA was cloned in the BamHI/XhoI sites of the pCCM803 vector downstream of the CMV promoter and in-frame with three copies of the flag epitope tag. This cDNA includes an additional exon at the 3 0 end (exon 7) that is not annotated in Wormbase [15] . The MBK-2 kinase dead (KD) mutation (K196R) in the kinase catalytic domain of MBK-2 was created by in vitro mutagenesis. A , and insoluble material was removed by centrifugation. Flag-MBK-2 and myc-GSK-3 were then immunoprecipitated from the lysates by anti-flag or anti-myc antibodies conjugated to agarose beads (Sigma). Beads were washed three times with lysis buffer and twice with kinase buffer, and then aliquoted for kinase assays.
For CK1 kinase assays, N-terminally GST-tagged rat CK1d purchased from Upstate (14-427) was used. Kinase assays were done in kinase buffer (50 mM HEPES [pH 7.4], 10 mM MgCl 2 , 10 mM DTT, 0.5 mM NaF, 0.1 mM Sodium vanadate [ortho], 100 mM ATP, 5 mg/ml leupeptin, and [g-32 P]ATP [6000 Ci/mmol; Amersham]) for 15 min at 25ºC. For MBK-2/CK1 or MBK-2/GSK-3 sequential kinase assays, substrate was first incubated with MBK-2 immobilized on agarose beads in the presence of 100 mM of nonradiolabeled ATP, and then transferred to a fresh tube to which CK1 or GSK-3 and [g-32 P]ATP were added. For CDK-1 immunoprecipitation and kinase assay, wild-type(N2), cdk-1(ne2257), and cks-1(ne549) mutants were grown at 15ºC and shifted to 25ºC at L4 stage. Eggs were collected from each strain at 25ºC and lysed in ice-cold CDK-1 buffer (50 mM Tris HCl [pH 7.4], 150 mM NaCl, 15 mM MgCl 2 , 1% NP-40, 60 mM b-glycerophosphate, 1 mM DTT, 0.1 mM Sodium vanadate [ortho], 0.1 mM PMSF, supplemented with Complete Mini protease inhibitor cocktail tablet [Roche]). After insoluble material was removed by centrifugation twice, CYB-1 or CYB-3 proteins were immunoprecipitated from the lysates by 1 hr incubation with anti-CYB-1 (1/5 dilution) or anti-CYB-3 (1/5 dilution) antibodies followed by another 1 hr incubation with Protein G beads (Roche) at 4ºC. Beads were washed three times with CDK-1 buffer and then boiled with SDS-PAGE sample buffer for immunoblotting. For kinase assays, beads were washed once more with 25 mM MOPS (pH 7.2), aliquoted, suspended into 6 ml of CDK-1 assay buffer (25 mM MOPS [pH 7.2], 60 mM b-glycerophosphate, 15 mM MgCl 2 , 1 mM DTT, 1 mM PMSF, 0.1 mM Sodium vanadate [ortho]), and incubated at room temperature for 5 min. Prewarmed beads were added to 10 ml of cocktail containing 25 mM MOPS (pH 7.2), 2 mg/ml Histone H1 (Roche), and [g-32 P]ATP (6000 Ci/mmol; Amersham) and incubated for 15 min at 25ºC. For CKS-1 pull-down assays, wild-type and mutant (F10Y encoded by ne549) CKS-1:: HIS(3x) proteins were expressed in E. coli, purified via Ni column, and crosslinked to Sepharose 4B (Pharmacia Biotech) beads. Extracts from wild-type and cdk-1(ne2257) embryos grown at 25ºC were incubated with CKS-1 beads, and associated CDK-1 proteins were detected by immunoblotting.
Live Embryo Imaging and Antibody Staining
Embryos harboring various GFP constructs were mounted in water on glass slides covered with 2% agarose. DIC and GFP images were captured at every 20 s with a Leica confocal microscope. For GFP images, at least three embryos were followed from the 1-cell stage in each strain and similar results were obtained. SKN-1 staining was performed as described previously [8] and multiple embryos were scored.
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